Colchicine . . . . and other stories
BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q466 (Published 29 February 2024) Cite this as: BMJ 2024;384:q466
Colchicine for people with type 2 diabetes and coronary heart disease
Trials show that low dose colchicine after a recent myocardial infarction has a modest protective effect against further cardiovascular events, probably through its anti-inflammatory effect. A secondary analysis of data from one of these trials suggests that the benefits apply particularly to people with type 2 diabetes. Among 1000 patients with type 2 diabetes and a recent myocardial infarction, subsequent cardiovascular events were reduced by around a third in those receiving 0.5 mg of colchicine daily (Diabetes Care doi:10.2337/dc23-1825).
False positive mammography
False positive mammography results are unfortunately very common. A longitudinal study from Sweden explores the long term implications. It followed 45 000 women who received a …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£33 / $40 / €36 (excludes VAT)
You can download a PDF version for your personal record.